Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology - Newswise

There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the

Newswise — There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting. This discr… [+2962 chars]

full article...